Neurology and Therapy
Scope & Guideline
Advancing Neurological Health Through Open Access Research
Introduction
Aims and Scopes
- Neurological Disorders and Treatments:
The journal focuses on a wide range of neurological conditions including Alzheimer's disease, multiple sclerosis, Parkinson's disease, epilepsy, and migraine, with a commitment to exploring both pharmacological and non-pharmacological treatments. - Patient-Centric Research:
A significant emphasis is placed on understanding patient experiences, treatment preferences, and quality of life. Research often incorporates qualitative methods to gauge patient perspectives on their conditions and treatments. - Innovative Therapeutic Approaches:
The journal highlights advancements in treatment modalities, including novel drug therapies, biologics, and emerging technologies such as deep brain stimulation and virtual reality interventions. - Real-World Evidence and Clinical Practice:
Research published often includes real-world studies and meta-analyses that assess the effectiveness and safety of treatments in diverse patient populations, thereby bridging the gap between clinical trials and everyday clinical practice. - Biomarkers and Diagnostic Tools:
The journal explores the development and application of biomarkers and diagnostic methods that aid in the early detection and management of neurological disorders, enhancing personalized treatment strategies.
Trending and Emerging
- Real-World Evidence and Patient Outcomes:
There is a growing trend towards studies that utilize real-world data to assess the effectiveness and safety of treatments, emphasizing the importance of patient outcomes and experiences in clinical decision-making. - Telehealth and Digital Therapeutics:
The rise of telehealth and digital therapeutic interventions has become a focal point, particularly in the context of the COVID-19 pandemic, as researchers explore their efficacy in managing neurological conditions. - Personalized Medicine and Biomarkers:
Research focusing on personalized medicine, particularly the use of biomarkers to tailor treatments to individual patient profiles, is increasingly prominent, reflecting advancements in genetic and molecular research. - Multimodal Approaches to Treatment:
An emerging trend is the exploration of multimodal treatment strategies that combine pharmacological, behavioral, and rehabilitation therapies, aiming for a more holistic approach to patient care. - Neuroinflammation and Neurodegeneration Research:
There is a notable increase in studies investigating the role of neuroinflammation in various neurological disorders, as researchers seek to uncover new therapeutic targets and mechanisms.
Declining or Waning
- Traditional Pharmacotherapy for Chronic Conditions:
There is a noticeable reduction in studies focusing solely on traditional pharmacological approaches to chronic neurological conditions, as the field increasingly embraces combination therapies and integrative treatment models. - Basic Science Research:
Research articles centered on basic science or purely mechanistic studies are becoming less frequent, possibly due to a shift in focus towards clinical applications and real-world effectiveness. - Longitudinal Studies:
The prevalence of longitudinal studies examining the long-term outcomes of treatments appears to be decreasing, potentially replaced by more immediate efficacy studies or innovative trial designs. - Conventional Rehabilitation Approaches:
There is a decline in publications focused on conventional rehabilitation methods, as newer technologies and therapeutic approaches (like virtual reality) gain traction in the field. - Epidemiological Studies of Rare Neurological Disorders:
Research on rare neurological disorders has seen a decrease, possibly due to the challenges in recruiting large cohorts and the increasing focus on more prevalent conditions or conditions with broader impact.
Similar Journals
Current Neuropharmacology
Leading the way in neuroscience and therapeutic advancements.Current Neuropharmacology is a premier journal dedicated to advancing the field of neuropharmacology, published by Bentham Science Publishers Ltd in the United Arab Emirates. As a leader in its domain, this journal has achieved a remarkable position in 2023, with Q1 rankings across several categories including Medicine (miscellaneous), Neurology, and Pharmacology. With a robust focus on the latest research related to pharmacological treatments and their neurological implications, Current Neuropharmacology features cutting-edge studies that inform clinical practices and psychiatric care. Although not open access, the journal offers both print and electronic formats to cater to a diverse audience of researchers, healthcare professionals, and students keen on accessing vital information in neuropharmacology. Its high impact within the academia is underscored by impressive Scopus rankings, confirming its importance as a vital resource for the ongoing exploration of mental health and neurotherapeutic innovations. With an engaging scope that encompasses emerging discoveries and clinical advancements, Current Neuropharmacology continues to be an essential platform for scholarly communication in the evolving landscape of neuroscience and pharmacology.
Journal of Clinical Neurology
Connecting Research and Practice in NeurologyThe Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.
CURRENT OPINION IN NEUROLOGY
Uncovering Breakthroughs in Neurological Research.CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.
NEUROLOGY
Connecting professionals with cutting-edge neurological findings.NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.
Aktualnosci Neurologiczne
Exploring the Frontiers of Neurological ScienceAktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.
Neurology Research International
Shaping the Future of Clinical NeurologyNeurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.
Degenerative Neurological and Neuromuscular Disease
Pioneering insights into neuromuscular challenges.Degenerative Neurological and Neuromuscular Disease is a distinguished academic journal published by DOVE MEDICAL PRESS LTD, focusing on the latest advancements in the field of neurology and neuromuscular disorders. With a commitment to disseminating high-quality research, the journal aims to provide a critical platform for researchers, healthcare professionals, and students to share and engage with groundbreaking studies that advance our understanding of degenerative conditions affecting the nervous system. Although the journal's impact factor and h-index are currently not available, its open access model ensures that the valuable findings published within are accessible to a global audience, thereby fostering collaboration and innovation in neurological health. The journal's address is PO BOX 300-008, Albany, Auckland 0752, New Zealand, reflecting its international relevance and commitment to advancing the field of neurology. As the understanding of neurodegenerative diseases and neuromuscular challenges continues to evolve, Degenerative Neurological and Neuromuscular Disease serves as an essential resource for anyone dedicated to improving patient outcomes and advancing scientific knowledge.
Clinical Parkinsonism & Related Disorders
Illuminating pathways to effective therapies.Clinical Parkinsonism & Related Disorders is a prominent open-access journal published by Elsevier, focused on advancing the understanding and treatment of Parkinson's disease and related neurological conditions. Since its inception in 2019, this journal has aimed to provide a platform for high-quality research, review articles, and clinical studies dedicated to elucidating the complexities of Parkinsonism and its comorbidities. With an E-ISSN of 2590-1125, it has swiftly established its role in the field of clinical neurology, currently ranked in the Q3 quartile for clinical neurology and Q4 for cellular and molecular neuroscience. While its Scopus rankings reflect a competitive landscape, occupying the 241st position in clinical neurology and the 83rd in neuroscience, the journal remains committed to fostering scholarly dialogue and supporting innovative research. Researchers, clinicians, and students will find valuable insights within its pages, contributing to ongoing discourse and the pursuit of effective therapeutic strategies. Access to all articles has been made available since 2019, emphasizing the journal's mission to disseminate knowledge widely and enhance accessibility in the scientific community.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
Shaping the future of pediatric neurological care.European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.
Current Journal of Neurology
Pioneering the future of neurological research and treatment.Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.